RO
Roivant Sciences
ROIV·NASDAQNew York NYFounded 2014300 employees
Mid CapbiotechPublicImmunologyDermatologyOncology
Platform: Vant Model
Market Cap
$8B
All Drugs
4
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (ROIV)
Loading ROIV stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ROI-9675 | ROI-9675 | NDA/BLA | 1 | HER2 | IPF | ||
| ROI-1081 | ROI-1081 | Phase 1/2 | 1 | PI3Kα | HNSCCHCC | ||
| Elrainavolisib | ROI-6440 | Preclinical | 1 | Nectin-4 | LGS | ||
| ROI-3353 | ROI-3353 | Phase 1/2 | 1 | PLK4 | ASCF |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)